When the economy goes into a downturn, even a plain-vanilla recession or near-recession and not a crisis, junk bonds behave badly. This is because over-indebted companies with iffy cash flows – those are the ones that are junk rated – begin to buckle….CLICK for complete article
U.S. demand for electric vehicles, including hybrids, could rise to 1.28 million by 2026, a new study projected on Wednesday, but most brands will struggle to make money on the new models….CLICK for complete article
Demand for liquefied natural gas (LNG) will continue to rise in the foreseeable future as global natural gas demand will grow exponentially with major emerging economies raising the share of gas in their energy mix….CLICK for complete article
I love reading about all the good news in the market. This past week, we saw U.S. jobless claims dip to 211,000, and they are now near half-century lows. We also saw U.S. consumer sentiment reach a 15-year high. So, what could go wrong? CLICK for complete article
Bicycle Therapeutics, which derives its name from a novel class of medicines it develops, is riding its way toward a Nasdaq listing.
Bicycle is a clinical-stage biopharma company and uses a novel class of medicines known as bicycles: synthetic short peptides constrained to form two loops, which provides stability and selectivity.
This unique therapeutic modality combines the pharmacology usually associated with a biologic with the manufacturing and pharmacokinetic properties of a small molecule…..CLICK for complete article
A new report projects the cannabis market in the United States will reach $22.7 billion in sales by 2023. The estimates in the Brightfield Group report imply a compound annual growth rate (CAGR) of 20 percent over the next four years.
The recreational market is expected to lead the charge, at least in 2019, delivering 33 percent growth, driven by a variety of factors including the stabilization of the market in California and new adult-use markets coming online….CLICK for complete article